Cartesian Therapeutics Strengthens Research and Innovation Leadership with appointment of Professor Christopher M. Jewell as Chief Scientific Officer
Gaithersburg, MD—February 14, 2023 – Cartesian Therapeutics, a fully integrated biopharmaceutical company pioneering RNA cell therapy for autoimmune diseases and cancer, today announced the appointment...




![[Figure1] Meniscus phenomenon](https://bioengineer.org/wp-content/uploads/2023/02/Smart-contact-lens-with-navigation-function-made-with-3D-printer-350x250.png)











